drugset / Trial / NCT02318225

Misoprostol Prior to Office Hysteroscopy in Patients With no Risk Factors for Experiencing Unacceptable Pain

NCT02318225

Phase 2 Unknown 100 enrolled Cairo University
RandomizedParallel-groupTriple-blindTreatment

Summary

The aim of this study is to assess whether vaginal misoprostol reduces pain during office hysteroscopy in parous patients with no risk factors for experiencing severe or unacceptable pain.

Timeline

Start
2015-01
Primary completion
2015-10
Completion
2015-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Misoprostol Other / unclassified 400 ug Other

Indications

No indication recorded.